TAKEDA-SHIRE: Shares in Japanese pharmaceutical company Takeda Pharmaceutical Co. tumbled 7 percent to in Tokyo on Wednesday after the company confirmed it had revised its offer for an approximately 50 percent stake in biotech company Shire Plc to 46 billion pounds ($64.2 billion). Shire's…
News
- Global stocks slip following sell-off on Wall Street
- $250 million medical research campus coming to Texas Medical Center
A sweeping medical research campus being planned for 30 acres of Texas Medical Center land will establish Houston as an international hub for biomedical innovations and bring together four of the city's powerhouse research institutions, officials said Monday afternoon. The project, called TMC3,…
- James Cantu Remains Undefeated with Unanimous Decision Victory Over Jairo Castaneda in San ...
SAN ANTONIO, TX - April 23, 2018 (Investorideas.com Newswire) This past Saturday TMB & PRB Entertainment presented, "Whose "O" Will Go", another successful boxing event that took place at the Mi Mercado Event Center in San Antonio, TX. In the 6-round main event, James Cantu (11-0, 4 KOs),…
- A biotech company's farthest-along drug just failed a key trial — and the stock is plummeting (PRTA)
Biotech company Prothena said on Monday that its drug to treat AL Amyloidosis, a rare disease in which amyloid protein builds up in the body and disrupts organ function, failed a key trial. The drug, NEOD001, failed a phase 2 trial, and the company decided to discontinue its later-stage phase 3…
- Life Sci Veteran Garabedian Talks Up Biotech Accelerator in Texas
Xconomy Texas —. San Antonio — For early stage researchers at universities and other institutions, the idea of finding enough money to bring a drug or medical device to market can seem daunting, if not entirely hopeless. Grants and angel networks can cover some preclinical funding, and big…